AstraZeneca Secures Global Rights to GPC3 CAR-T Therapy
Rockville, Md. and Shanghai, January 18, 2026 — AbelZeta Pharma, Inc. announced that AstraZeneca has agreed to acquire AbelZeta’s...
Mergers & Acquisitions for New Therapy
Zylox-Tonbridge Acquires Optimed to Drive Global MedTech Growth
HANGZHOU, China and BERLIN, January 16, 2026 — Zylox-Tonbridge, a Hong Kong–listed medical technology company focused on neurovascular and...
Fagron Expands U.S. Compounding Platform With UCP Deal
Nazareth, Belgium / Rotterdam, Netherlands | January 12, 2026 — Fagron has completed the acquisition of University Compounding Pharmacy...
NAMSA Acquires Labcorp Device Testing Assets to Expand MedTech
Toledo, Ohio — January 8, 2026 — NAMSA, a global leader in medical device testing, clinical research, and regulatory...
Lilly to Acquire Ventyx to Expand Oral Inflammation Therapies
INDIANAPOLIS | January 7, 2026 — Eli Lilly and Company has announced an agreement to acquire Ventyx Biosciences, a...
Merck Completes Cidara Acquisition to Strengthen Antiviral Pipeline
RAHWAY, New Jersey | January 7, 2026 — Merck has completed its acquisition of Cidara Therapeutics, marking a significant...
PharmaDrug Expands Botanical Pipeline With Canurta Stake
TORONTO | January 5, 2026 — PharmaDrug Inc. has completed the acquisition of an initial 19.9% equity interest in...
Ecovyst Completes Catalysts Sale to Technip Energies
WAYNE, PENNSYLVANIA | January 2, 2026 — Ecovyst Inc. announced the completion of the sale of its Advanced Materials...
AtaiBeckley Redomiciles to U.S., Aligning Pharma Strategy
New York | December 30, 2025 — AtaiBeckley Inc., a clinical-stage biopharmaceutical company focused on developing rapid-acting and scalable...
Emmaus Licenses Endari® in North America to NeoImmuneTech
Torrance, California | December 30, 2025 — Emmaus Life Sciences, Inc. has announced a strategic licensing and exclusive distribution...